In contrast, high AR activity in female patients showed a positive association with survival in lymphoid neoplasm diffuse large B-cell lymphoma (DLBC; HR = 0.41; 95% CI, 0.20–0.82; P = 0.011; Fig. 1D) and kidney renal papillary cell carcinoma (KIRP; HR = 0.76; 95% CI, 0.60–0.97; P = 0.026; Fig. 1D) and a negative association with uterine corpus endometrial carcinoma (UCEC; HR = 1.13; 95% CI, 1.02–1.24; P = 0.016; Fig. 1B), thyroid carcinoma (THCA; HR = 1.24; 95% CI, 1.03–1.49; P = 0.026; Fig. 1D), and PCPG (HR = 1.57; 95% CI, 1.02–2.42; P = 0.040; Fig. 1D). This evidence concerns the gene AR and uterine corpus endometrial carcinoma.